Journal of Immunotherapy and Precision Oncology
Innovative Healthcare Institute
About the journal
Journal of Immunotherapy and Precision Oncology is an open-access journal published by Innovative Healthcare Institute in United States, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 2,400 USD. Declared review time at DOAJ: 24 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Innovative Healthcare Institute
- ISSN
- 2666-2345 · 2590-017X
- Country
- United States
- Languages
- english
- Access
- Open access
- Declared publication charge
- 2,400 USD
- Articles in DOAJ
- 245
- Declared review time
- 24 weeks
- Declared peer-review model
- double_blind
- Official website
- https://meridian.allenpress.com/innovationsjournals-JIPO
Index listings
- DOAJ · 2022-11-30
- Indexing
- DOAJ
- APC
- 2,400 USD
- Declared review time (DOAJ)
- 24 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
245
Most recent article
2 months ago
Average review time (journal-declared via DOAJ)
24weeks
Works in OpenAlex
240
Last recorded publication year
2025
h-index
18
i10-index
42
From OpenAlex open data (CC0).
Editorial & policy12
- Last DOAJ review date
- 2022-12-19
- Added to DOAJ
- 2022-11-30
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSLOCKSSPMC
- Observed digital preservation (Keepers registry)— snapshot 2026-09-21
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Open references deposited at Crossref
- 93%
- ORCID iDs in current deposits
- 78%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity3
- Alternate titles
- JIPO
- Source type
- journal
- NLM unique ID (PubMed)
- 101768397
Classification4
Subjects (DOAJ)
LCC codes
Subject areas
- Cancer Immunotherapy and Biomarkers
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cancer Genomics and Diagnostics
- Cancer Genomics and Diagnostics
- CAR-T cell therapy research
- Lung Cancer Treatments and Mutations
- Lung Cancer Treatments and Mutations
Show all subjects (50)
- Immunotherapy and Immune Responses
- Immunotherapy and Immune Responses
- Colorectal Cancer Treatments and Studies
- Colorectal Cancer Treatments and Studies
- Lung Cancer Diagnosis and Treatment
- Lung Cancer Diagnosis and Treatment
- PARP inhibition in cancer therapy
- PARP inhibition in cancer therapy
- Chronic Lymphocytic Leukemia Research
- Chronic Lymphocytic Leukemia Research
- Immune Cell Function and Interaction
- Immune Cell Function and Interaction
- Sarcoma Diagnosis and Treatment
- Sarcoma Diagnosis and Treatment
- Lung Cancer Research Studies
- Lung Cancer Research Studies
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Protein Degradation and Inhibitors
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Protein Degradation and Inhibitors
- Economic and Financial Impacts of Cancer
- Economic and Financial Impacts of Cancer
- Colorectal and Anal Carcinomas
- Colorectal and Anal Carcinomas
- Drug-Induced Adverse Reactions
- HER2/EGFR in Cancer Research
- Lymphoma Diagnosis and Treatment
- Lymphoma Diagnosis and Treatment
- Drug-Induced Adverse Reactions
- Viral-associated cancers and disorders
- Melanoma and MAPK Pathways
- Pancreatic and Hepatic Oncology Research
- COVID-19 and healthcare impacts
- Viral-associated cancers and disorders
- Pancreatic and Hepatic Oncology Research
- COVID-19 and healthcare impacts
- Melanoma and MAPK Pathways
- HER2/EGFR in Cancer Research
- Acute Myeloid Leukemia Research
- Brain Metastases and Treatment
- Acute Myeloid Leukemia Research
- Brain Metastases and Treatment
Keywords (DOAJ)
- immunotherapy
- precision medicine
- oncology
- cancer
- targeted therapy
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ